Innovation Pharmaceuticals Stock Net Asset
IPIX Stock | USD 0 0.0002 15.38% |
Innovation Pharmaceuticals fundamentals help investors to digest information that contributes to Innovation Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Innovation Pink Sheet. The fundamental analysis module provides a way to measure Innovation Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Innovation Pharmaceuticals pink sheet.
Innovation |
Innovation Pharmaceuticals Company Net Asset Analysis
Innovation Pharmaceuticals' Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Innovation Pharmaceuticals Net Asset | 10.38 M |
Most of Innovation Pharmaceuticals' fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Innovation Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Competition |
Based on the recorded statements, Innovation Pharmaceuticals has a Net Asset of 10.38 M. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
Innovation Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Innovation Pharmaceuticals' direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Innovation Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Innovation Pharmaceuticals by comparing valuation metrics of similar companies.Innovation Pharmaceuticals is currently under evaluation in net asset category among related companies.
Innovation Fundamentals
Return On Equity | -1.09 | |||
Return On Asset | -0.32 | |||
Operating Margin | (339.83) % | |||
Current Valuation | 7.56 M | |||
Shares Outstanding | 488.32 M | |||
Shares Owned By Insiders | 10.10 % | |||
Price To Earning | (7.57) X | |||
Price To Book | 2.95 X | |||
Price To Sales | 557.16 X | |||
Revenue | 18 K | |||
Gross Profit | 18 K | |||
EBITDA | (6.54 M) | |||
Net Income | (7.04 M) | |||
Cash And Equivalents | 2.97 M | |||
Cash Per Share | 0.01 X | |||
Total Debt | 1.24 M | |||
Debt To Equity | 0.36 % | |||
Current Ratio | 0.60 X | |||
Book Value Per Share | 0.01 X | |||
Cash Flow From Operations | (6.28 M) | |||
Earnings Per Share | (0.02) X | |||
Beta | 0.18 | |||
Market Capitalization | 9.52 M | |||
Total Asset | 10.38 M | |||
Retained Earnings | (87.38 M) | |||
Working Capital | 44.72 K | |||
Current Asset | 529.15 K | |||
Current Liabilities | 484.43 K | |||
Z Score | -7.0 | |||
Net Asset | 10.38 M |
About Innovation Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Innovation Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Innovation Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Innovation Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innovation Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for Innovation Pink Sheet analysis
When running Innovation Pharmaceuticals' price analysis, check to measure Innovation Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovation Pharmaceuticals is operating at the current time. Most of Innovation Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Innovation Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovation Pharmaceuticals' price. Additionally, you may evaluate how the addition of Innovation Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |